Passive haemovigilance of blood components treated with a riboflavin-based pathogen reduction technology.
作者信息
Piotrowski Dariusz, Przybylska-Baluta Zofia, Jimenez-Marco Teresa, Kryzauskaite Lina, Papachronis Andreas, Marinaki Aliki, Höcker Paul, Wilde Sigrid Cherrier-de, Cardoso Marcia
机构信息
Regional Blood Transfusion Centre, Warsaw, Poland.
Blood and Tissue Bank Foundation of the Balearic Islands, Palma de Mallorca, Spain.
出版信息
Blood Transfus. 2018 Jul;16(4):348-351. doi: 10.2450/2017.0268-16. Epub 2017 Mar 23.
Abstract
摘要
相似文献
1
Passive haemovigilance of blood components treated with a riboflavin-based pathogen reduction technology.
Blood Transfus. 2018 Jul;16(4):348-351. doi: 10.2450/2017.0268-16. Epub 2017 Mar 23.
2
Evaluation of the post-transfusion platelet increment and safety of riboflavin-based pathogen reduction technology (PRT) treated platelet products stored in platelet additive solution for 5 days or less versus 6-7 days.
Transfus Apher Sci. 2016 Apr;54(2):248-52. doi: 10.1016/j.transci.2015.08.004. Epub 2015 Aug 28.
3
Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology.
Blood Transfus. 2017 Jul;15(4):357-364. doi: 10.2450/2017.0320-16. Epub 2017 May 11.
4
Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method.
Transfusion. 2015 Apr;55(4):815-23. doi: 10.1111/trf.12895. Epub 2014 Oct 29.
5
Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion.
Vox Sang. 2014 May;106(4):307-15. doi: 10.1111/vox.12106. Epub 2013 Oct 29.
6
Reduction of Leishmania donovani infectivity in whole blood using riboflavin and ultraviolet light.
Transfusion. 2015 Feb;55(2):326-9. doi: 10.1111/trf.12820. Epub 2014 Aug 25.
7
Treatment of platelet concentrates and plasma with riboflavin and UV light: Impact in bacterial reduction.
Transfus Clin Biol. 2018 Sep;25(3):197-203. doi: 10.1016/j.tracli.2018.03.004. Epub 2018 Apr 12.
8
Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
Transfusion. 2015 Apr;55(4):858-63. doi: 10.1111/trf.12945. Epub 2014 Dec 1.
9
Component pathogen inactivation: a critical review.
Vox Sang. 2013 Apr;104(3):183-99. doi: 10.1111/j.1423-0410.2012.01662.x. Epub 2012 Nov 8.
10
Development of a riboflavin and ultraviolet light-based device to treat whole blood.
Transfusion. 2013 Jan;53 Suppl 1:131S-136S. doi: 10.1111/trf.12047.
引用本文的文献
1
Haemostatic function measured by thromboelastography and metabolic activity of platelets treated with riboflavin and UV light.
Blood Transfus. 2020 Jul;18(4):280-289. doi: 10.2450/2020.0314-19. Epub 2020 May 15.
2
Contemporary resuscitation of hemorrhagic shock: What will the future hold?
Am J Surg. 2020 Sep;220(3):580-588. doi: 10.1016/j.amjsurg.2020.05.008. Epub 2020 May 11.
3
Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meeting.
Blood Transfus. 2019 Nov;17(6):433-448. doi: 10.2450/2019.0288-19. Epub 2019 Dec 11.
本文引用的文献
1
Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance.
Blood. 2016 Jan 28;127(4):496-502. doi: 10.1182/blood-2015-07-655944. Epub 2015 Nov 23.
2
A prospective, active haemovigilance study with combined cohort analysis of 19,175 transfusions of platelet components prepared with amotosalen-UVA photochemical treatment.
Vox Sang. 2015 Nov;109(4):343-52. doi: 10.1111/vox.12287. Epub 2015 May 15.
3
Chemical and biological mechanisms of pathogen reduction technologies.
Photochem Photobiol. 2014 Sep-Oct;90(5):957-64. doi: 10.1111/php.12311. Epub 2014 Aug 20.
4
A comparison of adverse reaction rates for PAS C versus plasma platelet units.
Transfusion. 2014 Aug;54(8):1927-34. doi: 10.1111/trf.12597. Epub 2014 Apr 16.
5
Hemovigilance and blood safety.
Asian J Transfus Sci. 2012 Jul;6(2):137-8. doi: 10.4103/0973-6247.98911.
6
Haemovigilance: an effective tool for improving transfusion practice.
Vox Sang. 2011 Jan;100(1):60-7. doi: 10.1111/j.1423-0410.2010.01442.x.
7
Pathogen inactivation: making decisions about new technologies. Report of a consensus conference.
Transfusion. 2007 Dec;47(12):2338-47. doi: 10.1111/j.1537-2995.2007.01512.x.
Zotero 插件